NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

When you say not the first, what other specific examples are you referring to? Seeing those examples might make the argument that this is similar more persuasive.

PPHM, now ticker CDMO, was a definite example.

Dev stage bio with some contract mfg facilities they owned (Avid). Built up Avid facilities while drug was still in trials. Longs cheered this on.

Drug flopped, Avid was a success. CDMO longs did well if they held through the long winter, but based on mfg ops, not the drug candidate (bavituximab).

The other example I would list is still a work in progress. CVM.